Our results showed that patients with invasive NFPAs had higher IL-10 expression both in peripheral blood and tumor tissue than those with noninvasive NFPAs, which indicates that IL-10 may play a vital role in the development of NFPAs and present a useful biomarker for diagnosis of invasive NFPAs. This evidence concerns the gene IL10 and neoplasm.